PRC1 could contribute to the early recurrence of HCC via the regulation of the Wnt/β-catenin signaling pathway, which has been proven to be a crucial pathway in hepatocarcinogenesis and a potential therapeutic target (Pez et al., 2013). Here, PRC1 is linked to hepatocellular carcinoma.